Showing results (61-70 of 258) with videos related to

Sort By:
Pageof 26
Japanese Journal of Clinical Oncology|April 2, 2014
Phase I study of carboplatin combined with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancerHiroaki Takeoka, Kazuhiko Yamada, Koichi Azuma, et al.
Oncotarget|December 2, 2017
Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinomaTakeharu Ono, Koichi Azuma, Akihiko Kawahara, et al.
Translational Lung Cancer Research|February 11, 2021
Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring EGFR mutationsRyo Ko, Takehito Shukuya, Chiyo K Imamura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 29, 2009
Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathyShin-ichiro Masuda, Kouichi Tamura, Hiromichi Wakui, et al.
Head & Neck|August 19, 2020
Predictive value of CD8/FOXP3 ratio combined with PD-L1 expression for radiosensitivity in patients with squamous cell carcinoma of the larynx receiving definitive radiation therapyTakeharu Ono, Koichi Azuma, Akihiko Kawahara, et al.
Plos One|June 5, 2019
Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinomaKazuki Takada, Mototsugu Shimokawa, Kensuke Tanaka, et al.
Lung Cancer (Amsterdam, Netherlands)|November 4, 2008
Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxelKoichi Azuma, Tetsuro Sasada, Akihiko Kawahara, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2010
Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapyYohei Imamura, Koichi Azuma, Seiji Kurata, et al.
Respiratory Investigation|March 10, 2015
Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosisMorihiro Tajiri, Masaki Okamoto, Kiminori Fujimoto, et al.
Lung Cancer (Amsterdam, Netherlands)|March 30, 2011
Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistryAkihiko Kawahara, Koichi Azuma, Akiko Sumi, et al.
Pageof 26